TY - CHAP
T1 - High-Dose Tirofiban
AU - Dawson, Bart
AU - Mukherjee, Debabrata
AU - Moliterno, David J.
PY - 2009/10/30
Y1 - 2009/10/30
KW - Acute coronary syndromes (ACS) undergoing PCI
KW - Glycoprotein (GP) IIb/IIIa inhibitors in reducing cardiovascular ischemic event
KW - High-dose tirofiban
KW - Major adverse cardiovascular events (MACE) after PCI
KW - Percutaneous coronary intervention (PCI)
KW - TENACITY (Tirofiban Evaluation of Novel Dosing vs Abciximab with Clopidogrel and Inhibition of Thrombin) trial
KW - Target vessel revascularization (TVR)
KW - Tirofiban - reducing pharmaceutical cost of PCI relative to abciximab
UR - http://www.scopus.com/inward/record.url?scp=84889345692&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84889345692&partnerID=8YFLogxK
U2 - 10.1002/9781444306347.ch19
DO - 10.1002/9781444306347.ch19
M3 - Chapter
AN - SCOPUS:84889345692
SN - 9781405157049
SP - 154
EP - 157
BT - Pharmacology in the Catheterization Laboratory
ER -